Childhood Pneumonia — Improving Paediatric Pneumonia Diagnosis Using Digital Auscultation
Citation(s)
Brooks D, Thomas J Interrater reliability of auscultation of breath sounds among physical therapists. Phys Ther. 1995 Dec;75(12):1082-8. doi: 10.1093/ptj/75.12.1082.
Emmanouilidou D, McCollum ED, Park DE, Elhilali M Computerized Lung Sound Screening for Pediatric Auscultation in Noisy Field Environments. IEEE Trans Biomed Eng. 2018 Jul;65(7):1564-1574. doi: 10.1109/TBME.2017.2717280. Epub 2017 Jun 19.
Gjlrup T, Bugge PM, Jensen AM Interobserver variation in assessment of respiratory signs. Physicians' guesses as to interobserver variation. Acta Med Scand. 1984;216(1):61-6. doi: 10.1111/j.0954-6820.1984.tb03772.x.
Grenier MC, Gagnon K, Genest J Jr, Durand J, Durand LG Clinical comparison of acoustic and electronic stethoscopes and design of a new electronic stethoscope. Am J Cardiol. 1998 Mar 1;81(5):653-6. doi: 10.1016/s0002-9149(97)00977-6.
Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016 Dec 17;388(10063):3027-3035. doi: 10.1016/S0140-6736(16)31593-8. Epub 2016 Nov 11. Erratum In: Lancet. 2017 May 13;389(10082):1884.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
